Jan. 10: “Improving Patient Outcomes via CAR T-Cell Therapy”
Dr. Andy Chen presents in this fall oncology lecture.
Oncology clinicians, Asante employees and the general public are invited to attend this lecture. Our guest speaker is Andy Chen, MD, PhD, who will present on “Improving Patient Outcomes via Chimeric Antigen Receptor T (CAR T)-Cell Therapy in Relapsed/Refractory Multiple Myeloma—Empowering Peer-to-Peer Education.”
This hour-long CME event takes place at:
Noon on Friday, Jan. 10
Mary and Dick Heimann Cancer Center
3011 E. Barnett Road, Medford
No registration is required, but space is limited.
Dr. Chen is a specialist in lymphoma and related malignancies. He is involved in research studying new treatments for lymphoma, and he has a particular interest in chimeric antigen receptor T cell (CAR-T) therapy. Dr. Chen attended Yale for college and then Harvard for his M.D. and Ph.D. in immunology research. He subsequently went to Stanford for residency and fellowship training before joining OHSU. He is past chair of the Patient Services Committee for the Oregon chapter of the Leukemia & Lymphoma Society and is co-chair of a national guideline committee for lymphoma.
